HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $551 | +6.4% | 7 | 0.0% | 0.00% | – |
| Q3 2022 | $518 | +13.6% | 7 | 0.0% | 0.00% | – |
| Q2 2022 | $456 | -51.9% | 7 | -53.3% | 0.00% | – |
| Q1 2022 | $948 | +155.5% | 15 | +114.3% | 0.00% | – |
| Q4 2021 | $371 | -97.2% | 7 | -93.9% | 0.00% | -100.0% |
| Q3 2018 | $13,177 | +5.0% | 115 | -17.9% | 0.01% | 0.0% |
| Q2 2018 | $12,555 | -79.1% | 140 | -82.9% | 0.01% | -79.1% |
| Q1 2018 | $60,064 | +26.0% | 821 | 0.0% | 0.04% | +22.9% |
| Q4 2017 | $47,684 | +29.4% | 821 | 0.0% | 0.04% | +25.0% |
| Q3 2017 | $36,838 | +13.6% | 821 | 0.0% | 0.03% | +7.7% |
| Q2 2017 | $32,421 | -2.7% | 821 | 0.0% | 0.03% | -7.1% |
| Q1 2017 | $33,308 | +0.9% | 821 | 0.0% | 0.03% | -6.7% |
| Q4 2016 | $33,004 | +11.0% | 821 | 0.0% | 0.03% | +11.1% |
| Q3 2016 | $29,728 | +24.9% | 821 | 0.0% | 0.03% | +22.7% |
| Q2 2016 | $23,801 | -44.2% | 821 | -32.6% | 0.02% | -45.0% |
| Q1 2016 | $42,641 | – | 1,219 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |